Creating a Cloud Platform to Solve the Automotive Recall Nightmare

The way we communicate, share data and use technology to act on those insights is changing – and it’s all leading to the cloud.

On In the Cloud, every week new experts will engage in a fire side chat and will bring their extensive experience in software, IT and mobile solutions straight to you, offering a glimpse into the future of cloud connectivity around.

The 21st-century vehicle depends just as much on software than hardware. Software is constantly evolving, so how are automakers keeping up to meet the growing demand for connected and autonomous vehicles? Answering that question and more, In the Cloud host Hilary Kennedy welcomed Hemant Sikaria, CEO of Sibros. Sibros is an automated cloud solution that manages software for connected vehicles.

“Connectivity is key to have autonomous and electric vehicles. Without a connectivity and management platform, you can’t have the modern vehicle,” Sikaria said.

“Even if someone is giving a command to a vehicle, it will still check the environment and be self-protecting. It will use its sensor and data to make the right decision.” – Heman Sikaria

After dealing with a frustrating process of recalls on vehicles that needed software updates, the idea of Sibros came to him. “It was surprising to me there wasn’t a better solution, Sikaria noted.

After all, 90 million cars are sold every year, so a productized platform makes sense. “There are both safety and security benefits for connected cars. Data collection from vehicles can help improve the safety of the vehicle,” Sikaria commented.

However, some may feel anxious about connectivity on this level due to the chance of a hack. Hollywood has stoked these worries, but Sikaria explained it’s far-fetched.

“Even if someone is giving a command to a vehicle, it will still check the environment and be self-protecting. It will use its sensor and data to make the right decision.”

The company works with many manufacturers, making it easy to integrate and at no cost. “We offer a product-based solution and usually pilot first. We continue to see quick adoption to our platform as manufacturers evolve into software companies.”

Stay Tuned For New Episodes

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

AI in marketing
From Queries to Conversations with AI in Marketing Analytics
April 21, 2025

In this episode of the SparkCast, Aby Varma—founder of Spark Novus, a firm that helps marketing leaders adopt AI responsibly and strategically—sits down with Daniel Kravtsov, CEO and Co-Founder of Improvado. Daniel shares his unique journey from Russia to founding a cutting-edge martech company in the Bay Area. Together, they explore how AI agents…

Read More
ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More